Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes

Background: Lung adenocarcinoma (LUAD) is the most common variant of non–small cell lung cancer (NSCLC) across the world. Recently, the rapid development of immunotherapy has brought a new dawn for LUAD patients. Closely related to the tumor immune microenvironment and immune cell functions, more an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Linbin Hua, Jiyue Wu, Jiashu Ge, Xin Li, Bin You, Wei Wang, Bin Hu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-05-01
Col·lecció:	Frontiers in Cell and Developmental Biology
Matèries:	lung adenocarcinoma (LUAD) immune checkpoints prognosis immunotherapy individualized treatment
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcell.2023.1060086/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!